An integrated scalp and blood biomarker approach suggests the systemic nature of alopecia areata.

This study contributes a unique understanding of the phenotype of moderate-to-severe AA with an integrated scalp and serum biomarker model suggesting the systemic nature of the disease, advocating for the need for immune-based systemic treatment.